DISEASE/TRAIT,RISK ALLELE FREQUENCY,P-VALUE,REGION,SNPS,MAPPED_GENE,Groups of Disease/Trait,MAPPED_TRAIT_URI,MAPPED_TRAIT_DESCRIPTION,RISK ALLELE FREQUENCY (%)
<<<<<<< Updated upstream
Metabolite levels (3-aminoisobutyrate; __Aminoisobutyrate),0.9605,2e-168,5p13.2,rs180749,AGXT2,Other trait,http://www.ebi.ac.uk/efo/EFO_0010980,Quantification of 3-aminoisobutyrate in a sample.,96.05
2-aminoisobutyric acid levels in chronic kidney disease,0.83,1e-62,5p13.2,rs180749,AGXT2,Other disease,http://www.ebi.ac.uk/efo/EFO_0801100,Quantification of the amount of 2-aminoisobutyric acid in a sample.,83.0
"Albumin (mean, inv-norm transformed)",0.7481,2e-19,1p35.1,rs16835227,RNF19B - AK2,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0004535,"An albumin measurement is a quantification of albumin in blood. Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca2+, Na+, K+, fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc. Low levels of albumin in the blood may indicate liver disease.",74.81
"Albumin (minimum, inv-norm transformed)",0.7481,8e-14,1p35.1,rs16835227,RNF19B - AK2,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0004535,"An albumin measurement is a quantification of albumin in blood. Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca2+, Na+, K+, fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc. Low levels of albumin in the blood may indicate liver disease.",74.81
Myeloproliferative neoplasms,0.6075,3e-07,3q21.3,rs9864772,LINC01565 - RPN1,Cancer,http://www.ebi.ac.uk/efo/EFO_0004251,"A clonal hematopoietic stem cell disorder, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, megakaryocytic, and mast cell) lineages. It is primarily a neoplasm of adults. (WHO 2008)",60.75000000000001
Trauma exposure,0.59,2e-08,19q13.32,rs770444611,CCDC8 - PNMA8C,Other trait,http://www.ebi.ac.uk/efo/EFO_0010703,Quantification of some aspect of trauma exposure.,59.0
Neuritic plaque,0.5847,2e-06,12p13.31,rs7294478,C1RL-AS1,Other trait,http://www.ebi.ac.uk/efo/EFO_0006798,"quantification of neuritic (senile) plaques in the brain, Senile plaques (also known as neuritic plaques, senile druse and braindruse) are extracellular deposits of amyloid beta in the grey matter of the brain.[1][2] Degenerative neural structures and an abundance of microglia and astrocytes can be associated with senile plaque deposits. These deposits can also be a byproduct of senescence (ageing). However, large numbers of senile plaques and neurofibrillary tangles are characteristic features of Alzheimer's disease. Abnormal neurites in senile plaques are composed primarily of paired helical filaments, a component of neurofibrillary tangles.[3] The plaques are variable in shape and size, but are on average 50 µm in size.[4] In Alzheimer's disease they are primarily composed of amyloid beta peptides.",58.47
Bioavailable testosterone levels,0.463062,5e-09,3p25.3,rs573833,ATP2B2,Other measurement,http://www.ebi.ac.uk/efo/EFO_0004908,"is a quantification of testosterone, typically in serum. Testosterone is a steroid hormone.Testosterone measurement is used in the diagnosis of precocious or delayed puberty, infertility (in men and women), ovarian tumours, adrenal tumours and pituitary disorders.",46.3062
"red cell diameter width (RDW, maximum, inv-norm transformed)",0.4373,3e-11,6p22.3,rs4441945,RPL21P61 - LNC-LBCS,Other trait,http://www.ebi.ac.uk/efo/EFO_0009188,"Red blood cell distribution width (RDW or RDW-CV or RCDW and RDW-SD) is a measure of the range of variation of red blood cell (RBC) volume that is reported as part of a standard complete blood count. Usually red blood cells are a standard size of about 6-8 μm in diameter. Certain disorders, however, cause a significant variation in cell size. Higher RDW values indicate greater variation in size. Normal reference range of RDW-CV in human red blood cells is 11.5-14.5%.[1] If anemia is observed, RDW test results are often used together with mean corpuscular volume (MCV) results to determine the possible causes of the anemia. It is mainly used to differentiate an anemia of mixed causes from an anemia of a single cause.",43.730000000000004
"red cell diameter width (RDW, mean, inv-norm transformed)",0.4373,1e-12,6p22.3,rs4441945,RPL21P61 - LNC-LBCS,Other trait,http://www.ebi.ac.uk/efo/EFO_0009188,"Red blood cell distribution width (RDW or RDW-CV or RCDW and RDW-SD) is a measure of the range of variation of red blood cell (RBC) volume that is reported as part of a standard complete blood count. Usually red blood cells are a standard size of about 6-8 μm in diameter. Certain disorders, however, cause a significant variation in cell size. Higher RDW values indicate greater variation in size. Normal reference range of RDW-CV in human red blood cells is 11.5-14.5%.[1] If anemia is observed, RDW test results are often used together with mean corpuscular volume (MCV) results to determine the possible causes of the anemia. It is mainly used to differentiate an anemia of mixed causes from an anemia of a single cause.",43.730000000000004
"COVID-19 (hospitalized vs tested, not hospitalized)",0.38723602,8e-06,6p22.3,rs493024,ID4 - RPL29P17,Other measurement,http://purl.obolibrary.org/obo/MONDO_0100096,A disease caused by infection with severe acute respiratory syndrome coronavirus 2.,38.723602
COVID-19 (hospitalized vs population),0.38503273,4e-06,6p22.3,rs493024,ID4 - RPL29P17,Other trait,http://purl.obolibrary.org/obo/MONDO_0100096,A disease caused by infection with severe acute respiratory syndrome coronavirus 2.,38.503273
"What is your weight? (pounds, inv-normal transformed)",0.2229,9.000000000000001e-23,3q21.3,rs4073154,H1-10-AS1,Body measurement,http://www.ebi.ac.uk/efo/EFO_0004338,The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.,22.29
Appendicular lean mass,0.2216,2e-33,3q21.3,rs4073154,H1-10-AS1,Body measurement,http://www.ebi.ac.uk/efo/EFO_0004980,Appendicular lean mass is a measurement of skeletal strength of lower limbs and is used as a predictive measure of hip fracture.,22.16
"What is your height? (cm, inv-normal transformed)",0.208,3e-26,3q21.3,rs4073154,H1-10-AS1,Body measurement,http://www.ebi.ac.uk/efo/EFO_0004339,The distance from the sole to the crown of the head with body standing on a flat surface and fully extended.,20.8
=======
Ratio of omega-3 fatty acids to total fatty acids,0.992377,7e-10,11q12.3,rs116956494,INCENP,Lipid or lipoprotein measurement,http://www.ebi.ac.uk/efo/EFO_0005110,The determination of the amount of fatty acids present in a sample.,99.23769999999999
Ratio of omega-6 fatty acids to omega-3 fatty acids,0.992377,2e-09,11q12.3,rs116956494,INCENP,Lipid or lipoprotein measurement,http://www.ebi.ac.uk/efo/EFO_0005110,The determination of the amount of fatty acids present in a sample.,99.23769999999999
Docosahexaenoic acid levels,0.992377,6e-10,11q12.3,rs116956494,INCENP,Other trait,http://www.ebi.ac.uk/efo/EFO_0007761,The determination of the amount of docosahexaenoic acid present in a sample.,99.23769999999999
Omega-3 fatty acid levels,0.992377,2e-09,11q12.3,rs116956494,INCENP,Lipid or lipoprotein measurement,http://www.ebi.ac.uk/efo/EFO_0010119,A quantification of omega-3 fatty acid in a sample.,99.23769999999999
Breast cancer,0.979,4e-07,14q24.3,rs9323635,LINC02289,Cancer,http://www.ebi.ac.uk/efo/EFO_0000305,A carcinoma that arises from epithelial cells of the breast,97.89999999999999
Metabolite levels (3-aminoisobutyrate; __Aminoisobutyrate),0.9605,2e-168,5p13.2,rs180749,AGXT2,Other trait,http://www.ebi.ac.uk/efo/EFO_0010980,Quantification of 3-aminoisobutyrate in a sample.,96.05
Appendicular lean mass,0.942827,2e-33,10p11.23,rs776620768,ZNF438,Body measurement,http://www.ebi.ac.uk/efo/EFO_0004980,Appendicular lean mass is a measurement of skeletal strength of lower limbs and is used as a predictive measure of hip fracture.,94.28269999999999
"Allergic disease (asthma, hay fever or eczema)",0.93,6e-11,1p34.3,rs76167968,Y_RNA - ZMYM4,Immune system disease,http://purl.obolibrary.org/obo/MONDO_0005271,"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.",93.0
Educational attainment,0.9226,3e-37,1p35.1,rs28438078,CSMD2,Other trait,http://www.ebi.ac.uk/efo/EFO_0011015,A measure of academic performance through educational benchmarks such as national exams and curriculum assessments.,92.25999999999999
Drinks per week,0.906,2e-16,19q13.2,rs2217342,ATP1A3,Other trait,http://www.ebi.ac.uk/efo/EFO_0007878,quantification of some aspect of alcohol consumption such as frequency or quantity,90.60000000000001
Chronotype,0.9011,2e-10,16q13,rs6499821,GNAO1-DT,Other trait,http://www.ebi.ac.uk/efo/EFO_0008328,quantification of some aspect of chronotype such as ease of getting up in the morning,90.11
"eosinophil (fraction, mean, inv-norm transformed)",0.8819,6e-30,1p22.3,rs1888342,LINC02801,Other trait,http://www.ebi.ac.uk/efo/EFO_0004842,Is a quantification of eosinphils in blood.,88.19
Platelet count,0.875528,5e-20,11q24.3,rs2268607,FLI1,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004309,The number of PLATELETS per unit volume in a sample of venous BLOOD.,87.55279999999999
Prostate-specific antigen levels,0.871,7e-58,19q13.33,rs2735839,KLK3 - KLK2,Immune system disease,http://purl.obolibrary.org/obo/OBA_2050200,Ontology not covered,87.1
Hepatitis A virus cellular receptor 2 level in Chronic kidney disease with hypertension and no diabetes (5134_52),0.87,7e-21,5q33.3,rs977257,HAVCR2,Cardiovascular disease,http://www.ebi.ac.uk/efo/EFO_0008151,quantification of the amount of hepatitis A virus cellular receptor 2 in a sample,87.0
Neuritic plaque,0.87,2e-06,12p13.31,rs7294478,C1RL-AS1,Other trait,http://www.ebi.ac.uk/efo/EFO_0006798,"quantification of neuritic (senile) plaques in the brain, Senile plaques (also known as neuritic plaques, senile druse and braindruse) are extracellular deposits of amyloid beta in the grey matter of the brain.[1][2] Degenerative neural structures and an abundance of microglia and astrocytes can be associated with senile plaque deposits. These deposits can also be a byproduct of senescence (ageing). However, large numbers of senile plaques and neurofibrillary tangles are characteristic features of Alzheimer's disease. Abnormal neurites in senile plaques are composed primarily of paired helical filaments, a component of neurofibrillary tangles.[3] The plaques are variable in shape and size, but are on average 50 µm in size.[4] In Alzheimer's disease they are primarily composed of amyloid beta peptides.",87.0
"eosinophil (absolute count, maximum, inv-norm transformed)",0.8602,1e-13,1p22.3,rs1888342,LINC02801,Other trait,http://www.ebi.ac.uk/efo/EFO_0004842,Is a quantification of eosinphils in blood.,86.02
"eosinophil (absolute count, mean, inv-norm transformed)",0.8602,9e-19,1p22.3,rs1888342,LINC02801,Other trait,http://www.ebi.ac.uk/efo/EFO_0004842,Is a quantification of eosinphils in blood.,86.02
"eosinophil (fraction, minimum, inv-norm transformed)",0.8596,9e-16,1p22.3,rs1888342,LINC02801,Other trait,http://www.ebi.ac.uk/efo/EFO_0004842,Is a quantification of eosinphils in blood.,85.96000000000001
"eosinophil (fraction, maximum, inv-norm transformed)",0.8596,1.0000000000000001e-23,1p22.3,rs1888342,LINC02801,Other trait,http://www.ebi.ac.uk/efo/EFO_0004842,Is a quantification of eosinphils in blood.,85.96000000000001
Atrial fibrillation,0.85084,3e-25,10q22.2,rs10824026,"SYNPO2L-AS1, SYNPO2L",Other trait,http://www.ebi.ac.uk/efo/EFO_0000275,"A disorder characterized by an electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregular ventricular response. (CDISC)",85.084
Platelet forward scatter distribution width,0.8423,1e-34,19q13.42,rs1654447,RDH13,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0005036,A measurement quantifying some platelet,84.23
Intraocular pressure,0.84,7e-07,3q21.2,rs893830,KALRN,Other trait,http://www.ebi.ac.uk/efo/EFO_0004695,Is a quantification of intraocular pressure. Increased intraocular pressure is a heritable risk factor for primary open angle glaucoma.,84.0
COVID-19,0.83583351,4e-06,5q15,rs159602,MCTP1,Other trait,http://purl.obolibrary.org/obo/MONDO_0100096,A disease caused by infection with severe acute respiratory syndrome coronavirus 2.,83.583351
"Basophil (absolute count, maximum, inv-norm transformed)",0.8355,2e-43,1p22.3,rs11161968,LINC02801,Other trait,http://www.ebi.ac.uk/efo/EFO_0803539,"Quantification of some aspect of basophils, such as function, quantity or composition.",83.55
"Basophil (absolute count, mean, inv-norm transformed)",0.8355,7e-53,1p22.3,rs11161968,LINC02801,Other trait,http://www.ebi.ac.uk/efo/EFO_0803539,"Quantification of some aspect of basophils, such as function, quantity or composition.",83.55
"eosinophil (absolute count, minimum, inv-norm transformed)",0.8344,9e-15,1p22.3,rs11161968,LINC02801,Other trait,http://www.ebi.ac.uk/efo/EFO_0004842,Is a quantification of eosinphils in blood.,83.44
"Basophil (fraction, mean, inv-norm transformed)",0.8316,1e-107,1p22.3,rs11161968,LINC02801,Other trait,http://www.ebi.ac.uk/efo/EFO_0803539,"Quantification of some aspect of basophils, such as function, quantity or composition.",83.16
"Basophil (fraction, maximum, inv-norm transformed)",0.8316,1e-81,1p22.3,rs11161968,LINC02801,Other trait,http://www.ebi.ac.uk/efo/EFO_0803539,"Quantification of some aspect of basophils, such as function, quantity or composition.",83.16
2-aminoisobutyric acid levels in chronic kidney disease,0.83,1e-62,5p13.2,rs180749,AGXT2,Other disease,http://www.ebi.ac.uk/efo/EFO_0801100,Quantification of the amount of 2-aminoisobutyric acid in a sample.,83.0
Smoking initiation,0.814,3e-77,11p15.1,rs7122118,TPH1,Other trait,http://www.ebi.ac.uk/efo/EFO_0005670,"initation of the habit of smoking, the inhaling and exhaling of tobacco smoke.",81.39999999999999
Post bronchodilator FEV1/FVC ratio,0.812,3e-06,15q25.1,rs2568497,CRABP1 - IREB2,Other trait,"http://www.ebi.ac.uk/efo/EFO_0004713, http://purl.obolibrary.org/obo/GO_0097366",,81.2
Post bronchodilator FEV1,0.811,2e-07,15q25.1,rs2568497,CRABP1 - IREB2,Other trait,"http://www.ebi.ac.uk/efo/EFO_0004314, http://purl.obolibrary.org/obo/GO_0097366",,81.10000000000001
"mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed)",0.7941,3e-14,16p11.2,rs17677,AHSP,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004528,The mean corpuscular hemoglobin concentration is a measure of the concentration of hemoglobin in a given volume of packed red blood cell,79.41
Corneal resistance factor (MTAG),0.79,5e-09,14q24.2,rs2535903,DCAF4 - ZFYVE1,Other trait,http://www.ebi.ac.uk/efo/EFO_0010067,A measure of the biomechanical properties of the cornea. Low corneal resistance factor may be indicative of keratoconus.,79.0
"hematocrit (maximum, inv-norm transformed)",0.7699,2e-21,19q13.33,rs10412446,NOSIP,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004348,"The volume of packed RED BLOOD CELLS in a blood specimen. The volume is measured by centrifugation in a tube with graduated markings, or with automated blood cell counters. It is an indicator of erythrocyte status in disease. For example, ANEMIA shows a low value; POLYCYTHEMIA, a high value.",76.99000000000001
"hemoglobin (maximum, inv-norm transformed)",0.7699,1.9999999999999998e-26,19q13.33,rs10412446,NOSIP,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004509,Hemoglobin measurement is a measure of the quantity of the metallo protein hemoglobin in blood often used in the diagnosis of anaemia.,76.99000000000001
"red blood cell count (RBC, maximum, inv-norm transformed)",0.7698,5e-34,19q13.33,rs10412446,NOSIP,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004305,The number of red blood cells per unit volume in a sample of venous blood.,76.98
Trauma exposure,0.767228,2e-08,19q13.32,rs770444611,CCDC8 - PNMA8C,Other trait,http://www.ebi.ac.uk/efo/EFO_0010703,Quantification of some aspect of trauma exposure.,76.7228
Principal component-derived dietary pattern 1,0.766982,8e-27,18q21.32,rs17782313,RNU4-17P - MC4R,Other trait,http://www.ebi.ac.uk/efo/EFO_0008111,"quantification of some aspect of diet, including diet patterns, balance of nutrient consumption and glycemic load",76.6982
Adult body size,0.766902,3e-104,18q21.32,rs58084604,RNU4-17P - MC4R,Other trait,http://www.ebi.ac.uk/efo/EFO_0004339,The distance from the sole to the crown of the head with body standing on a flat surface and fully extended.,76.6902
Chronic ulcer of leg or foot (PheCode 707.2),0.7636,1e-11,18q21.32,rs17782313,RNU4-17P - MC4R,Digestive system disease,http://www.ebi.ac.uk/efo/EFO_0007068,Ulcer of lower limbs is a chronic ulcer of skin where the ulcer is not a decubitus ulcer.,76.36
Atrial fibrillation (PheCode 427.21),0.7482,2e-19,6p22.3,rs34969716,KDM1B,Other trait,http://www.ebi.ac.uk/efo/EFO_0000275,"A disorder characterized by an electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregular ventricular response. (CDISC)",74.82
"Albumin (minimum, inv-norm transformed)",0.7481,8e-14,1p35.1,rs16835227,RNF19B - AK2,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0004535,"An albumin measurement is a quantification of albumin in blood. Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca2+, Na+, K+, fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc. Low levels of albumin in the blood may indicate liver disease.",74.81
"Albumin (mean, inv-norm transformed)",0.7481,2e-19,1p35.1,rs16835227,RNF19B - AK2,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0004535,"An albumin measurement is a quantification of albumin in blood. Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca2+, Na+, K+, fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc. Low levels of albumin in the blood may indicate liver disease.",74.81
Atrial fibrillation and flutter (PheCode 427.2),0.7481,2e-18,6p22.3,rs34969716,KDM1B,Other trait,http://www.ebi.ac.uk/efo/EFO_0000275,"A disorder characterized by an electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregular ventricular response. (CDISC)",74.81
Chronic lymphocytic leukemia,0.73,9e-08,16q24.1,rs305061,LINC02132 - LINC01082,Cancer,http://www.ebi.ac.uk/efo/EFO_0000095,"B-cell chronic lymphocytic leukemia (B-CLL) is a type of B-cell non-Hodgkin lymphoma, and the most common form of leukemia in Western countries, affecting elderly adults (mean age of 67 and 72 years) with a slight male predominance (1.7:1), and characterized by a highly variable clinical presentation that can include asymptomatic disease or non-specific B-symptoms such as unintentional weight loss, severe fatigue, fever (without evidence of infection), and night sweats as well as cervical lymphadenopathy, splenomegaly and frequent infections. Some patients can also develop autoimmune complications such as autoimmune hemolytic anemia or immune thrombocytopenia. The clinical course is extremely heterogeneous with survival ranging from a few months to several decades.",73.0
25-hydroxyvitamin D levels (skin colour stratified),0.72,6e-10,7p15.3,rs10085881,SP4 - DNAH11,Other trait,http://www.ebi.ac.uk/efo/EFO_0004631,"A quantification of Vitamin D levels, typically in blood. Vitamin D includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE (MeSH). 25-hydroxyvitamin D or calcifediol, a prehormone precursor of vitamin D, is widely used as a proxy to quanitfy vitamin D levels in blood.",72.0
Asthma and hay fever,0.72,1e-08,16p13.13,rs62026376,CLEC16A,Immune system disease,"http://purl.obolibrary.org/obo/MONDO_0004979, http://www.ebi.ac.uk/efo/EFO_0003956",,72.0
Serum 25-Hydroxyvitamin D levels (conditioned on BMI),0.717815,2e-11,7p15.3,rs10085881,SP4 - DNAH11,Body measurement,http://www.ebi.ac.uk/efo/EFO_0004631,"A quantification of Vitamin D levels, typically in blood. Vitamin D includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE (MeSH). 25-hydroxyvitamin D or calcifediol, a prehormone precursor of vitamin D, is widely used as a proxy to quanitfy vitamin D levels in blood.",71.7815
Principal component-derived dietary pattern 3,0.715399,2e-09,22q13.1,rs2269608,KCNJ4,Other trait,http://www.ebi.ac.uk/efo/EFO_0008111,"quantification of some aspect of diet, including diet patterns, balance of nutrient consumption and glycemic load",71.5399
Ratio of monounsaturated fatty acids to total fatty acids,0.715066,3e-11,22q11.21,rs5746638,PRODH,Lipid or lipoprotein measurement,http://www.ebi.ac.uk/efo/EFO_0005110,The determination of the amount of fatty acids present in a sample.,71.50659999999999
"Albumin (maximum, inv-norm transformed)",0.7138,4e-13,1p35.1,rs150944423,RNF19B - AK2,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0004535,"An albumin measurement is a quantification of albumin in blood. Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca2+, Na+, K+, fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc. Low levels of albumin in the blood may indicate liver disease.",71.38
Multiple sclerosis,0.702,1e-06,1p36.32,rs60733400,TNFRSF14 - PRXL2B,Immune system disease,http://purl.obolibrary.org/obo/MONDO_0005301,A progressive autoimmune disorder affecting the central nervous system resulting in demyelination. Patients develop physical and cognitive impairments that correspond with the affected nerve fibers.,70.19999999999999
Reticulocyte count,0.693733,2e-11,20p13,rs554743,ADAM33,Other trait,http://www.ebi.ac.uk/efo/EFO_0007986,The number of reticulocytes per unit volume of blood. Reticulocytes are immature red blood cells and typically compose aoubt 1% of red blood cells in the human body.,69.3733
Phospholipids to total lipids ratio in medium HDL,0.693151,5e-11,6p21.31,rs2744973,ILRUN,Lipid or lipoprotein measurement,"http://www.ebi.ac.uk/efo/EFO_0020946, http://www.ebi.ac.uk/efo/EFO_0004612",,69.3151
Phospholipids to total lipids ratio in large LDL,0.693151,2e-40,11q12.2,rs174566,"FADS1, FADS2",Lipid or lipoprotein measurement,"http://www.ebi.ac.uk/efo/EFO_0004611, http://www.ebi.ac.uk/efo/EFO_0020946",,69.3151
Free cholesterol to total lipids ratio in medium HDL,0.693151,6.9999999999999996e-161,11q12.2,rs174566,"FADS1, FADS2",Cardiovascular disease,"http://www.ebi.ac.uk/efo/EFO_0020945, http://www.ebi.ac.uk/efo/EFO_0004612",,69.3151
Mucinous epithelial ovarian cancer,0.69,6e-06,8q24.21,rs6470494,"CASC19, PCAT1",Cancer,http://www.ebi.ac.uk/efo/EFO_0006462,"An invasive adenocarcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that contain intracytoplasmic mucin. There is cellular atypia, increased layering of cells, complexity of glands, and papillary formations.",69.0
"height (mean, inv-normal transformed)",0.6762,3.999999999999999e-54,10p11.23,rs11008281,ZNF438,Body measurement,http://www.ebi.ac.uk/efo/EFO_0004339,The distance from the sole to the crown of the head with body standing on a flat surface and fully extended.,67.62
"height (minimum, inv-normal transformed)",0.6762,1e-51,10p11.23,rs11008281,ZNF438,Body measurement,http://www.ebi.ac.uk/efo/EFO_0004339,The distance from the sole to the crown of the head with body standing on a flat surface and fully extended.,67.62
"Height (maximum, inv-normal transformed)",0.675,9e-52,10p11.23,rs2000099,ZNF438,Body measurement,http://www.ebi.ac.uk/efo/EFO_0004339,The distance from the sole to the crown of the head with body standing on a flat surface and fully extended.,67.5
"Basophil (absolute count, minimum, inv-norm transformed)",0.6743,4e-11,17q21.1,rs35272691,PSMD3 - CSF3,Other trait,http://www.ebi.ac.uk/efo/EFO_0803539,"Quantification of some aspect of basophils, such as function, quantity or composition.",67.43
Immature platelet count,0.6726,2e-21,6p22.2,rs2281073,CARMIL1 - SCGN,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0803544,The number of immature platelets in a specified volume of blood.,67.25999999999999
Elevated white blood cell count (PheCode 288.2),0.671,6e-35,17q21.1,rs35272691,PSMD3 - CSF3,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004308,The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells.,67.10000000000001
Glutathione S-transferase Mu 3 levels,0.67,0.0,1p13.3,rs3754446,GSTM2 - GSTM5,Other trait,http://www.ebi.ac.uk/efo/EFO_0004747,"Is a quantification of some protein, typically obtained from an individual with the intention of using the measurement in some diagnostic process.",67.0
Basophil count,0.666338,5e-38,1p22.3,rs1888341,LINC02801,Other trait,http://www.ebi.ac.uk/efo/EFO_0005090,"The number of granulocytes (polymorphonuclear leukocytes) in a specified volume of blood, usually 1 cubic millimeter.",66.6338
Metabolite levels (aminoisobutyric_acid; 2-aminoisobutyric acid),0.6629,7.999999999999997e-32,5p13.2,rs344156,AGXT2,Other trait,http://www.ebi.ac.uk/efo/EFO_0801100,Quantification of the amount of 2-aminoisobutyric acid in a sample.,66.29
1-docosapentaenoyl-GPC (22:5n6) levels,0.6624,4e-43,11q12.2,rs174567,"FADS2, FADS1",Other trait,http://www.ebi.ac.uk/efo/EFO_0800364,Quantification of the amount of 1-docosapentaenoyl-GPC (22:5n6) in a sample.,66.24
Sodium-coupled monocarboxylate transporter 1 levels,0.66,3e-13,11q12.2,rs174566,"FADS1, FADS2",Other trait,http://www.ebi.ac.uk/efo/EFO_0802076,Quantification of sodium-coupled monocarboxylate transporter 1 in a sample.,66.0
2-arachidonoyl-GPE (20:4) levels,0.6585,7e-146,11q12.2,rs174567,"FADS2, FADS1",Other trait,http://www.ebi.ac.uk/efo/EFO_0800260,Quantification of the amount of 2-arachidonoyl-GPE (20:4) in a sample.,65.85
1-adrenoyl-GPC (22:4) levels,0.6583,5e-108,11q12.2,rs174567,"FADS2, FADS1",Other trait,http://www.ebi.ac.uk/efo/EFO_0800321,Quantification of the amount of 1-adrenoyl-GPC (22:4) in a sample.,65.83
Hand grip strength,0.658,4e-12,17q21.32,rs2288278,"HOXB3, HOXB-AS3",Other trait,http://www.ebi.ac.uk/efo/EFO_0006941,quantification of the force applied by the hand to pull on or suspend from objects,65.8
Triglycerides,0.6572,1e-22,11p11.2,rs7120118,NR1H3,Lipid or lipoprotein measurement,http://www.ebi.ac.uk/efo/EFO_0004530,"A triglyceride measurement is a quantification of triglycerides in some body fluid, used as a biomarker for cardiovascular disease.",65.72
1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n6) levels,0.6566,6e-69,11q12.2,rs174567,"FADS2, FADS1",Other trait,http://www.ebi.ac.uk/efo/EFO_0800456,Quantification of the amount of 1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n6) in a sample.,65.66
1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3) levels,0.6562,1e-62,11q12.2,rs174567,"FADS2, FADS1",Other trait,http://www.ebi.ac.uk/efo/EFO_0800455,Quantification of the amount of 1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3) in a sample.,65.62
1-arachidonoyl-GPE (20:4n6) levels,0.656,2.0000000000000005e-237,11q12.2,rs174567,"FADS2, FADS1",Other trait,http://www.ebi.ac.uk/efo/EFO_0800248,Quantification of the amount of 1-arachidonoyl-GPE (20:4n6) in a sample.,65.60000000000001
1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5) levels,0.6559,5e-152,11q12.2,rs174567,"FADS2, FADS1",Other trait,http://www.ebi.ac.uk/efo/EFO_0800408,Quantification of the amount of 1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5) in a sample.,65.59
1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels,0.6559,2e-62,11q12.2,rs174567,"FADS2, FADS1",Other trait,http://www.ebi.ac.uk/efo/EFO_0800404,Quantification of the amount of 1-stearoyl-2-linoleoyl-GPC (18:0/18:2) in a sample.,65.59
"hemoglobin (mean, inv-norm transformed)",0.6554,2e-15,19q13.33,rs10412446,NOSIP,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004509,Hemoglobin measurement is a measure of the quantity of the metallo protein hemoglobin in blood often used in the diagnosis of anaemia.,65.53999999999999
"hematocrit (mean, inv-norm transformed)",0.6554,4e-14,19q13.33,rs10412446,NOSIP,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004348,"The volume of packed RED BLOOD CELLS in a blood specimen. The volume is measured by centrifugation in a tube with graduated markings, or with automated blood cell counters. It is an indicator of erythrocyte status in disease. For example, ANEMIA shows a low value; POLYCYTHEMIA, a high value.",65.53999999999999
"red blood cell count (RBC, mean, inv-norm transformed)",0.655,7e-19,19q13.33,rs10412446,NOSIP,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004305,The number of red blood cells per unit volume in a sample of venous blood.,65.5
"red blood cell count (RBC, minimum, inv-norm transformed)",0.655,5e-14,19q13.33,rs10412446,NOSIP,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004305,The number of red blood cells per unit volume in a sample of venous blood.,65.5
Highest math class taken,0.6527,2e-10,1q42.12,rs55755259,STUM,Other trait,http://www.ebi.ac.uk/efo/EFO_0004875,"Is the mental process necessary to acquire knowledge or skill in the measurement, properties, and relationships of quantities and sets, using numbers and symbols (mathematics)",65.27
Free cholesterol levels in HDL,0.651878,1e-83,11q12.2,rs174566,"FADS1, FADS2",Cardiovascular disease,"http://www.ebi.ac.uk/efo/EFO_0008591, http://www.ebi.ac.uk/efo/EFO_0004612",,65.1878
Albumin levels,0.650071,2e-09,19p13.11,rs8107347,ELL,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0004535,"An albumin measurement is a quantification of albumin in blood. Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca2+, Na+, K+, fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc. Low levels of albumin in the blood may indicate liver disease.",65.0071
Apolipoprotein A1 levels,0.649794,9e-65,11q12.2,rs174566,"FADS1, FADS2",Lipid or lipoprotein measurement,http://www.ebi.ac.uk/efo/EFO_0004614,Is a quantification of apolipoprotein A 1 in a sample. It is encoded in humans by the APOA1 gene and is the major protein component of high density lipoprotein (HDL) in plasma. Apolipoprotein A 1 relates to lower observational risk of coronary artery disease.,64.9794
Estimated glomerular filtration rate (creatinine),0.6479,3e-17,19p13.11,rs1469024,IQCN,Other trait,http://www.ebi.ac.uk/efo/EFO_0005208,"measurement of the flow rate of filtered fluid through the kidney, calculated either by comparative measurements of substances in the blood and urine, or estimated from a blood test",64.79
Free cholesterol to total lipids ratio in small LDL,0.6468,9e-28,11q12.2,rs174567,"FADS2, FADS1",Cardiovascular disease,"http://www.ebi.ac.uk/efo/EFO_0004611, http://www.ebi.ac.uk/efo/EFO_0020945",,64.68
Total cholesterol to total lipids ratio in very large HDL,0.6462,3e-46,11q12.2,rs174567,"FADS2, FADS1",Cardiovascular disease,"http://www.ebi.ac.uk/efo/EFO_0020943, http://www.ebi.ac.uk/efo/EFO_0004612",,64.62
Cholesteryl esters to total lipids ratio in very large HDL,0.6456,2.9999999999999995e-54,11q12.2,rs174567,"FADS2, FADS1",Lipid or lipoprotein measurement,"http://www.ebi.ac.uk/efo/EFO_0020944, http://www.ebi.ac.uk/efo/EFO_0004612",,64.56
Phospholipids to total lipids ratio in small LDL,0.645,6.999999999999999e-42,11q12.2,rs174567,"FADS2, FADS1",Lipid or lipoprotein measurement,"http://www.ebi.ac.uk/efo/EFO_0004611, http://www.ebi.ac.uk/efo/EFO_0020946",,64.5
Phospholipids to total lipids ratio in medium LDL,0.645,2e-51,11q12.2,rs174567,"FADS2, FADS1",Lipid or lipoprotein measurement,"http://www.ebi.ac.uk/efo/EFO_0004611, http://www.ebi.ac.uk/efo/EFO_0020946",,64.5
Triglycerides to total lipids ratio in medium VLDL,0.6449,5e-132,11q12.2,rs174566,"FADS1, FADS2",Lipid or lipoprotein measurement,"http://www.ebi.ac.uk/efo/EFO_0020947, http://www.ebi.ac.uk/efo/EFO_0008317",,64.49000000000001
Free cholesterol to total lipids ratio in medium LDL,0.6449,9e-20,11q12.2,rs174566,"FADS1, FADS2",Cardiovascular disease,"http://www.ebi.ac.uk/efo/EFO_0004611, http://www.ebi.ac.uk/efo/EFO_0020945",,64.49000000000001
Triglycerides to total lipids ratio in IDL,0.6448,1e-63,11q12.2,rs174566,"FADS1, FADS2",Lipid or lipoprotein measurement,"http://www.ebi.ac.uk/efo/EFO_0020947, http://www.ebi.ac.uk/efo/EFO_0008595",,64.48
Phospholipids to total lipids ratio in IDL,0.6439,1e-67,11q12.2,rs174566,"FADS1, FADS2",Lipid or lipoprotein measurement,"http://www.ebi.ac.uk/efo/EFO_0020946, http://www.ebi.ac.uk/efo/EFO_0008595",,64.39
Concentration of very small VLDL particles,0.6435,5e-36,11q12.2,rs174566,"FADS1, FADS2",Lipid or lipoprotein measurement,http://www.ebi.ac.uk/efo/EFO_0008317,quantification of the amount of very low density lipoprotein cholesterol in a sample,64.35
"Remnant cholesterol (non-HDL, non-LDL -cholesterol)",0.6434,3e-24,11q12.2,rs174566,"FADS1, FADS2",Cardiovascular disease,http://www.ebi.ac.uk/efo/EFO_0010815,"Measurement of remnant cholesterol (remnant lipoprotein), which is an atherogenic lipoprotein composed primarily of very low-density lipoprotein (VLDL) and intermediate-density lipoprotein (IDL).",64.34
Triglycerides in very large HDL,0.6433,8e-15,11q12.2,rs174566,"FADS1, FADS2",Lipid or lipoprotein measurement,http://www.ebi.ac.uk/efo/EFO_0022324,Quantification of triglycerides in very large HDL.,64.33
Lymphocyte count,0.64215,4e-31,7q32.3,rs7793008,LINC-PINT,Other trait,http://www.ebi.ac.uk/efo/EFO_0004587,A quantification of lymphocytes in blood.,64.215
Cholesterol esters in very large HDL,0.6391,1e-18,11p11.2,rs7120118,NR1H3,Cardiovascular disease,"http://www.ebi.ac.uk/efo/EFO_0008589, http://www.ebi.ac.uk/efo/EFO_0004612",,63.91
Concentration of very large HDL particles,0.6391,9.999999999999999e-27,11p11.2,rs7120118,NR1H3,Lipid or lipoprotein measurement,http://www.ebi.ac.uk/efo/EFO_0004612,The measurement of HDL cholesterol in blood used as a risk indicator for heart disease.,63.91
Total lipids in very large HDL,0.6391,9.999999999999999e-27,11p11.2,rs7120118,NR1H3,Lipid or lipoprotein measurement,http://www.ebi.ac.uk/efo/EFO_0022312,Quantification of total lipids in very large HDL.,63.91
Total cholesterol levels in very large HDL,0.639,9e-21,11p11.2,rs7120118,NR1H3,Cardiovascular disease,"http://www.ebi.ac.uk/efo/EFO_0004574, http://www.ebi.ac.uk/efo/EFO_0004612",,63.9
Mean diameter of HDL particles,0.639,3.0000000000000003e-31,11p11.2,rs7120118,NR1H3,Lipid or lipoprotein measurement,http://www.ebi.ac.uk/efo/EFO_0008592,"Quantification of the size of HDL particles, typically their diameter.",63.9
Free cholesterol in very large HDL,0.6389,3e-25,11p11.2,rs7120118,NR1H3,Cardiovascular disease,http://www.ebi.ac.uk/efo/EFO_0022273,Quantification of free cholesterol in very large HDL.,63.89
Hypopotassemia (PheCode 276.14),0.6344,2e-11,5q23.3,rs7726795,FBN2,Other trait,http://purl.obolibrary.org/obo/MONDO_0003019,"Any disorder caused by an insufficient amount or availability of potassium, which generally manifests with myalgia, tetany, hypotension, polyuria, and polydipsia.",63.44
Smoking initiation (ever regular vs never regular) (MTAG),0.633,4e-20,2q36.3,rs4674993,NYAP2,Other trait,http://www.ebi.ac.uk/efo/EFO_0006527,"self-reported binary measure, used to denote whether an individual is currently or has ever been a smoker",63.3
Diseases of white blood cells (PheCode 288),0.6319,3e-34,17q21.1,rs35272691,PSMD3 - CSF3,Hematological measurement,http://purl.obolibrary.org/obo/MONDO_0015978,Description not found,63.190000000000005
"Plasma 2,6-dihydroxybenzoic acid levels in chronic kidney disease",0.63,5e-18,3q29,rs2342307,"PCYT1A, SLC51A",Other disease,http://www.ebi.ac.uk/efo/EFO_0801046,"Quantification of the amount of 2,6-dihydroxybenzoic acid in a sample.",63.0
Menopause (age at onset),0.63,1e-08,14q24.2,rs8010674,DCAF4 - ZFYVE1,Other trait,http://www.ebi.ac.uk/efo/EFO_0004704,"The age of onset of (human) menopause, the beginning of the first menstrual cycle in an individual",63.0
Clear cell renal cell carcinoma,0.63,1e-10,10p11.23,rs793096,LINC02664,Cancer,http://www.ebi.ac.uk/efo/EFO_0000349,A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network. The tumor may metastasize to unusual sites and late metastasis is common.,63.0
Plateletcrit,0.627322,4e-20,11q24.3,rs2268607,FLI1,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0007985,"The proportion of blood volume that is occupied by platelets, expressed as a percentage.",62.732200000000006
Metabolite levels (leucylserine),0.6215,2e-13,4q35.2,rs4253281,KLKB1,Other trait,http://purl.obolibrary.org/obo/OBA_2050361,Ontology not covered,62.150000000000006
Edge-level brain connectivity (multivariate analysis),0.620789,7e-16,7q21.11,rs10155886,SEMA3A,Nervous system disease,http://www.ebi.ac.uk/efo/EFO_0005210,quantification of the pattern of links between distinct units within a nervous system through neuroimaging techniques such a MRI,62.078900000000004
Pyruvate levels,0.6173,5e-12,22q11.21,rs9605972,CLTCL1,Other trait,http://www.ebi.ac.uk/efo/EFO_0010117,A quantification of pyruvate in a sample.,61.73
Citrate levels,0.6168,1e-59,22q11.21,rs9605972,CLTCL1,Other trait,http://www.ebi.ac.uk/efo/EFO_0010114,A quantification of citrate in a sample.,61.68
Depression,0.614875,1e-07,15q21.1,rs8040348,SEMA6D,Mental disorder,http://purl.obolibrary.org/obo/MONDO_0002009,An episode of depression lasting two or more weeks without an intervening episode of mania.,61.4875
Myeloproliferative neoplasms,0.6075,3e-07,3q21.3,rs9864772,LINC01565 - RPN1,Cancer,http://www.ebi.ac.uk/efo/EFO_0004251,"A clonal hematopoietic stem cell disorder, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, megakaryocytic, and mast cell) lineages. It is primarily a neoplasm of adults. (WHO 2008)",60.75000000000001
Externalizing behaviour (multivariate analysis),0.602,4e-12,10p11.23,rs61841113,JCAD,Other trait,"http://www.ebi.ac.uk/efo/EFO_0003888, http://purl.obolibrary.org/obo/MONDO_0002491, http://www.ebi.ac.uk/efo/EFO_0007052",,60.199999999999996
Educational attainment (MTAG),0.6017,1e-57,2q11.2,rs13018640,AFF3 - LINC01104,Other trait,http://www.ebi.ac.uk/efo/EFO_0004784,"A measure of educational progress reported using a questionnaire based approach, often used as a proxy for cognitive performance as the two are correlated.",60.17
Dementia with Lewy bodies,0.6,1e-08,16p11.2,rs897984,"MIR4519, BCL7C, MIR762HG",Nervous system disease,http://www.ebi.ac.uk/efo/EFO_0006792,"A progressive form of dementia characterized by the presence of protein deposits called Lewy bodies in the midbrain and cerebral cortex, and loss of cholinergic and dopaminergic neurons. The signs and symptoms overlap with Alzheimer and Parkinson disease.",60.0
Glycine levels,0.5906,3e-12,2q34,rs1861072,UNC80,Other trait,http://www.ebi.ac.uk/efo/EFO_0009767,Quantification of the amount of the amino acid glycine in a sample.,59.06
Alzheimer's disease with no specific cognitive domain impairment,0.59,4e-06,2q31.1,rs4972634,LINC01960 - RPSAP24,Nervous system disease,http://purl.obolibrary.org/obo/MONDO_0004975,"A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.",59.0
Smoking cessation,0.59,9e-13,3p12.3,rs9833290,ROBO2,Other trait,http://www.ebi.ac.uk/efo/EFO_0004319,"Discontinuation of the habit of smoking, the inhaling and exhaling of tobacco smoke.",59.0
Body size at age 10,0.586164,1e-31,3p22.2,rs2268762,ACVR2B,Other trait,http://www.ebi.ac.uk/efo/EFO_0009819,"Description of an individual's body size at age 10 compared to average, as reported by the individual.",58.6164
Metabolite levels (arginine),0.5805,2e-11,4q35.2,rs4253281,KLKB1,Other trait,http://www.ebi.ac.uk/efo/EFO_0020990,Quanitification of argininine levels in a sample.,58.050000000000004
Ewing sarcoma,0.58,4e-17,10q21.3,rs224278,EGR2 - RNU6-543P,Cancer,http://www.ebi.ac.uk/efo/EFO_0000174,"A small round cell tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewing sarcoma/peripheral neuroectodermal tumor. It affects mostly males under age 20, and it can occur in soft tissue or bone. Pain and the presence of a mass are the most common clinical symptoms.",57.99999999999999
JT interval,0.5784,8e-99,17q24.2,rs8071250,PRKCA,Other trait,http://www.ebi.ac.uk/efo/EFO_0007885,"measurement of the repolarisation phase of the heart's electrical cycle, defined as the difference between the duration of the QT interval and duration of the QRS interval",57.84
Free cholesterol to total lipids ratio in very large VLDL,0.577315,2e-12,8p23.1,rs11986122,MSRA,Cardiovascular disease,"http://www.ebi.ac.uk/efo/EFO_0008317, http://www.ebi.ac.uk/efo/EFO_0020945",,57.731500000000004
Cholesterol to total lipids ratio in medium VLDL,0.577225,2e-16,8p23.1,rs11986122,MSRA,Cardiovascular disease,"http://www.ebi.ac.uk/efo/EFO_0008317, http://www.ebi.ac.uk/efo/EFO_0020943",,57.7225
Cholesteryl esters to total lipids ratio in medium VLDL,0.577225,1e-16,8p23.1,rs11986122,MSRA,Lipid or lipoprotein measurement,"http://www.ebi.ac.uk/efo/EFO_0008317, http://www.ebi.ac.uk/efo/EFO_0020944",,57.7225
Hemoglobin A1c levels,0.577,1e-18,11q12.2,rs174566,"FADS1, FADS2",Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004541,A quantification of glycated A1c hemoglobin in blood used as an index for blood glucose level over several months.,57.699999999999996
Migraine - clinic-based,0.56,4e-06,6q25.2,rs2186141,RNU6-896P - HMGB3P19,Nervous system disease,http://purl.obolibrary.org/obo/MONDO_0005277,"A common, severe type of vascular headache often associated with increased sympathetic activity, resulting in nausea, vomiting, and light sensitivity.",56.00000000000001
Heparin-induced thrombocytopenia,0.56,9e-06,12q24.33,rs905227,ZNF84,Hematological measurement,"http://purl.obolibrary.org/obo/OBA_2040023, http://purl.obolibrary.org/obo/HP_0001873",,56.00000000000001
Electrocardiogram morphology (amplitude at temporal datapoints),0.555249,3e-11,11q22.1,rs671333,ARHGAP42,Cardiovascular disease,http://www.ebi.ac.uk/efo/EFO_0004327,"Recording of the moment-to-moment electromotive forces of theÂ HEARTÂ as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is aÂ CATHODE RAY TUBE DISPLAY.",55.5249
Mean corpuscular hemoglobin,0.551759,2e-21,17q11.2,rs10853129,MIR4732 - FLOT2,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004527,The MCH is the average mass of hemoglobin per red blood cell in a sample of blood and is calculated by dividing the total mass of hemoglobin by the RBC count,55.1759
IgA nephropathy,0.5479392320332094,8e-08,1p36.13,rs2240335,PADI4,Immune system disease,http://www.ebi.ac.uk/efo/EFO_0004194,A chronic form of glomerulonephritis characterized by deposits of predominantly immunoglobulin A in the mesangial area (glomerular mesangium). Deposits of complement C3 and immunoglobulin G are also often found. Clinical features may progress from asymptomatic hematuria to end-stage kidney disease.,54.79392320332094
Mean platelet volume,0.542183,2e-298,17q11.2,rs9891920,TAOK1,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004584,A measurement of mean platelet volume is a machine-calculated measurement of the average size of platelets found in blood,54.2183
Immature granulocyte count,0.538,9e-26,17q21.1,rs8071037,PSMD3,Other trait,http://www.ebi.ac.uk/efo/EFO_0803542,The number of immature granulocytes in a specified volume of blood.,53.800000000000004
Depressive symptoms (MTAG),0.5313,7e-09,14q24.3,rs4553560,PROX2,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0007006,"quantification of the existence and severity of depressive symptoms, usually via a questionnaire such as the Center for Epidemiological Studies Depression Scale (CES-D)",53.13
Plasma N-acetylkynurenine (2) levels in chronic kidney disease,0.52,1e-14,6p22.2,rs6905614,SLC17A3,Other disease,http://www.ebi.ac.uk/efo/EFO_0800083,Quantification of the amount of N-acetylkynurenine (2) in a sample.,52.0
Transmembrane glycoprotein NMB levels (GPNMB.8606.39.3),0.512,4e-16,4q35.2,rs4253282,KLKB1,Other trait,http://www.ebi.ac.uk/efo/EFO_0008303,quantification of the amount of transmembrane glycoprotein NMB in a sample,51.2
Inhibin beta C chain levels (INHBC.6408.2.3),0.512,5e-12,4q35.2,rs4253282,KLKB1,Other trait,http://www.ebi.ac.uk/efo/EFO_0801696,Quantification of inhibin beta C chain in a sample.,51.2
"prostate-specific antigen (PSA, minimum, inv-norm transformed)",0.5113,2e-31,16q23.1,rs12448922,ADAMTS18 - LINC02131,Immune system disease,http://purl.obolibrary.org/obo/OBA_2050200,Ontology not covered,51.129999999999995
"prostate-specific antigen (PSA, mean, inv-norm transformed)",0.5112,7.0000000000000006e-34,16q23.1,rs12448922,ADAMTS18 - LINC02131,Immune system disease,http://purl.obolibrary.org/obo/OBA_2050200,Ontology not covered,51.12
"prostate-specific antigen (PSA, maximum, inv-norm transformed)",0.5112,3e-33,16q23.1,rs12448922,ADAMTS18 - LINC02131,Immune system disease,http://purl.obolibrary.org/obo/OBA_2050200,Ontology not covered,51.12
Monocyte count,0.5097,9e-44,16q24.1,rs305064,LINC02132 - LINC01082,Other trait,http://www.ebi.ac.uk/efo/EFO_0005091,quantification of monocytes in the blood,50.970000000000006
Hippocampal subfield left CA1 volume (head),0.50409,8e-15,10q26.13,rs1055256,EEF1AKMT2,Other trait,http://www.ebi.ac.uk/efo/EFO_0009394,"Volume of hippocampal CA1, which is the part of hippocampus proper bounded by CA2 and the subiculum, characterized by pyramidal neurons that receive projections from pyramidal neurons of CA3 via the Schaffer collaterals.",50.409000000000006
Left hippocampal volume (head),0.50409,9e-20,10q26.13,rs1055256,EEF1AKMT2,Other trait,http://www.ebi.ac.uk/efo/EFO_0005035,Measurement of the volume of the hippocampus,50.409000000000006
Left presubiculum volume (head),0.50409,1e-09,10q26.13,rs1055256,EEF1AKMT2,Other trait,http://www.ebi.ac.uk/efo/EFO_0009400,Volume of subiculum region in hippocampus.,50.409000000000006
Highest math class taken (MTAG),0.5009,6e-20,6q16.1,rs12208753,MMS22L - MIR2113,Other trait,http://www.ebi.ac.uk/efo/EFO_0004875,"Is the mental process necessary to acquire knowledge or skill in the measurement, properties, and relationships of quantities and sets, using numbers and symbols (mathematics)",50.09
"Gut microbiota (bacterial taxa, rank normal transformation method)",0.500889047969768,5e-06,17q12,rs317386,ASIC2,Digestive system disease,http://www.ebi.ac.uk/efo/EFO_0007874,quantification of some aspect of an individual's micrbiome of the gut,50.0889047969768
Core binding factor acute myeloid leukemia,0.499,4e-25,1p35.1,rs1493995; rs11590251; rs1690551; rs6693247; rs2336245; rs12122667; rs1389561; rs5007951; rs16835593,CSMD2; CSMD2; CSMD2; CSMD2; CSMD2; CSMD2; CSMD2; CSMD2; CSMD2,Cancer,http://www.ebi.ac.uk/efo/EFO_0000222,"Acute myeloid leukemia (AML) is a group of neoplasms arising from precursor cells committed to the myeloid cell-line differentiation. All of them are characterized by clonal expansion of myeloid blasts. AML manifests by fever, pallor, anemia, hemorrhages and recurrent infections.",49.9
Alanine levels,0.496,3e-10,8q24.3,rs2306386,RECQL4,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0009765,Quantification of the amount of the amino acid alanine in a sample.,49.6
Illicit drug use,0.492,9e-06,17q25.3,rs4788985,SEPTIN9,Response to drug,http://www.ebi.ac.uk/efo/EFO_0005431,The consumption of illegal drug such as heroine. Note that some drug like cannabis are illegal in some countries but legal in others.,49.2
Serum metabolite levels,0.491175,3e-56,11q12.2,rs174567,"FADS2, FADS1",Other trait,http://www.ebi.ac.uk/efo/EFO_0005653,quantification of some metabolite in serum,49.1175
Secondary hypothyroidism (PheCode 244.1),0.4908,3e-15,14q13.2,rs1742869,LINC00609,Metabolic disease,http://www.ebi.ac.uk/efo/EFO_0004705,Abnormally low levels of thyroid hormone.,49.08
Mitochondrial DNA levels,0.4821,5e-23,20p11.23,rs11697739,SNX5,Other trait,http://www.ebi.ac.uk/efo/EFO_0006312,"quantification of mitochondrial DNA in a sample, usually through genetic amplification of target genes by quantifiative real-time PCR",48.209999999999994
Bile salt-activated lipase levels,0.479964,2e-13,10p11.23,rs793095,LINC02664,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0004747,"Is a quantification of some protein, typically obtained from an individual with the intention of using the measurement in some diagnostic process.",47.9964
Uterine fibroids,0.4791,8e-09,13q14.11,rs6563812,LINC00598,Other trait,http://www.ebi.ac.uk/efo/EFO_0000731,"A benign smooth muscle neoplasm arising from the body of the uterus. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern.",47.910000000000004
Neuropilin-2 levels,0.4727,1e-24,4q35.2,rs4253281,KLKB1,Nervous system disease,http://purl.obolibrary.org/obo/OBA_2042642,Ontology not covered,47.27
Plasma maltol sulfate levels in chronic kidney disease,0.47,2e-15,16p11.2,rs193628,SGF29,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0004725,The quantification of some metabolite.,47.0
"Body mass index (BMI, minimum, inv-normal transformed)",0.4683,4e-20,2p23.3,rs59086897,ADCY3 - DNAJC27,Body measurement,http://www.ebi.ac.uk/efo/EFO_0004340,"An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight (kg)/height squared (m2). BMI correlates with body fat (ADIPOSE TISSUE). Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 (underweight); 18.5-24.9 (normal); 25.0-29.9 (overweight); 30.0 and above (obese). (National Center for Health Statistics, Centers for Disease Control and Prevention)",46.83
"Body mass index (BMI, mean, inv-normal transformed)",0.4683,9.000000000000001e-23,2p23.3,rs59086897,ADCY3 - DNAJC27,Body measurement,http://www.ebi.ac.uk/efo/EFO_0004340,"An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight (kg)/height squared (m2). BMI correlates with body fat (ADIPOSE TISSUE). Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 (underweight); 18.5-24.9 (normal); 25.0-29.9 (overweight); 30.0 and above (obese). (National Center for Health Statistics, Centers for Disease Control and Prevention)",46.83
"Body mass index (BMI, maximum, inv-normal transformed)",0.4683,5e-24,2p23.3,rs59086897,ADCY3 - DNAJC27,Body measurement,http://www.ebi.ac.uk/efo/EFO_0004340,"An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight (kg)/height squared (m2). BMI correlates with body fat (ADIPOSE TISSUE). Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 (underweight); 18.5-24.9 (normal); 25.0-29.9 (overweight); 30.0 and above (obese). (National Center for Health Statistics, Centers for Disease Control and Prevention)",46.83
Isobutyrylcarnitine levels,0.4637,6e-27,15q24.2,rs2959850,"ETFA, TMEM266",Other trait,http://www.ebi.ac.uk/efo/EFO_0021023,Quantification of the amount of isobutyrylcarnitine in a sample.,46.37
Bioavailable testosterone levels,0.463062,5e-09,3p25.3,rs573833,ATP2B2,Other measurement,http://www.ebi.ac.uk/efo/EFO_0004908,"is a quantification of testosterone, typically in serum. Testosterone is a steroid hormone.Testosterone measurement is used in the diagnosis of precocious or delayed puberty, infertility (in men and women), ovarian tumours, adrenal tumours and pituitary disorders.",46.3062
Mitochondrial DNA copy number (raw),0.46018,4e-50,17q21.1,rs3859187,PSMD3,Other trait,http://www.ebi.ac.uk/efo/EFO_0006312,"quantification of mitochondrial DNA in a sample, usually through genetic amplification of target genes by quantifiative real-time PCR",46.018
Urinary metabolite levels in chronic kidney disease,0.46,4e-20,16q24.3,rs2250598,DPEP1,Other disease,http://www.ebi.ac.uk/efo/EFO_0005116,quantification of some metabolite in urine,46.0
Urine X-17674 levels in chronic kidney disease,0.46,2e-15,16p11.2,rs193628,SGF29,Other disease,http://www.ebi.ac.uk/efo/EFO_0004725,The quantification of some metabolite.,46.0
Urine prolylglycine levels in chronic kidney disease,0.46,0.0,16q24.3,rs2434858,DPEP1,Other disease,http://www.ebi.ac.uk/efo/EFO_0800683,Quantification of the amount of prolylglycine in a sample.,46.0
Urine maltol sulfate levels in chronic kidney disease,0.46,9e-18,16p11.2,rs193628,SGF29,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0004725,The quantification of some metabolite.,46.0
Male-pattern baldness,0.452029,2e-09,12q24.21,rs35514224,TBX3-AS1 - UBA52P7,Other trait,http://www.ebi.ac.uk/efo/EFO_0007825,quantification of the amount of balding in an individual,45.2029
Serum levels of protein CHRDL2,0.448,2e-17,11q13.4,rs6592590,POLD3 - RN7SKP297,Other trait,http://www.ebi.ac.uk/efo/EFO_0007937,quantification of the levels of some protein in a blood sample,44.800000000000004
"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",0.447,2e-13,16p13.13,rs2041733,CLEC16A,Immune system disease,"http://purl.obolibrary.org/obo/MONDO_0005271, http://www.ebi.ac.uk/efo/EFO_0004847",,44.7
"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",0.447,2e-13,16p13.13,rs2041733,CLEC16A,Immune system disease,http://purl.obolibrary.org/obo/MONDO_0005271,"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.",44.7
"neutrophil (fraction, mean, inv-norm transformed)",0.445,3e-211,17q21.1,rs8070444,PSMD3,Other trait,http://www.ebi.ac.uk/efo/EFO_0004833,"The number of granulocytes (polymorphonuclear leukocytes) in a specified volume of blood, usually 1 cubic millimeter.",44.5
"neutrophil (absolute count, maximum, inv-norm transformed)",0.4449,5e-220,17q21.1,rs8070444,PSMD3,Other trait,http://www.ebi.ac.uk/efo/EFO_0004833,"The number of granulocytes (polymorphonuclear leukocytes) in a specified volume of blood, usually 1 cubic millimeter.",44.49
"lymphocyte (fraction, maximum, inv-norm transformed)",0.4439,6e-148,17q21.1,rs8070444,PSMD3,Other trait,http://www.ebi.ac.uk/efo/EFO_0004587,A quantification of lymphocytes in blood.,44.39
"lymphocyte (fraction, mean, inv-norm transformed)",0.4439,3e-145,17q21.1,rs8070444,PSMD3,Other trait,http://www.ebi.ac.uk/efo/EFO_0004587,A quantification of lymphocytes in blood.,44.39
Cytomegalovirus antibody response,0.44,5e-06,12p13.32,rs4766152,CRACR2A,Response to drug,http://purl.obolibrary.org/obo/GO_0009615,Description not found,44.0
Metabolite levels (arachidonoylcholine),0.4388,2e-85,11q12.2,rs174567,"FADS2, FADS1",Other trait,http://www.ebi.ac.uk/efo/EFO_0800478,Quantification of the amount of arachidonoylcholine in a sample.,43.88
"red cell diameter width (RDW, maximum, inv-norm transformed)",0.4373,3e-11,6p22.3,rs4441945,RPL21P61 - LNC-LBCS,Other trait,http://www.ebi.ac.uk/efo/EFO_0009188,"Red blood cell distribution width (RDW or RDW-CV or RCDW and RDW-SD) is a measure of the range of variation of red blood cell (RBC) volume that is reported as part of a standard complete blood count. Usually red blood cells are a standard size of about 6-8 μm in diameter. Certain disorders, however, cause a significant variation in cell size. Higher RDW values indicate greater variation in size. Normal reference range of RDW-CV in human red blood cells is 11.5-14.5%.[1] If anemia is observed, RDW test results are often used together with mean corpuscular volume (MCV) results to determine the possible causes of the anemia. It is mainly used to differentiate an anemia of mixed causes from an anemia of a single cause.",43.730000000000004
"red cell diameter width (RDW, mean, inv-norm transformed)",0.4373,1e-12,6p22.3,rs4441945,RPL21P61 - LNC-LBCS,Other trait,http://www.ebi.ac.uk/efo/EFO_0009188,"Red blood cell distribution width (RDW or RDW-CV or RCDW and RDW-SD) is a measure of the range of variation of red blood cell (RBC) volume that is reported as part of a standard complete blood count. Usually red blood cells are a standard size of about 6-8 μm in diameter. Certain disorders, however, cause a significant variation in cell size. Higher RDW values indicate greater variation in size. Normal reference range of RDW-CV in human red blood cells is 11.5-14.5%.[1] If anemia is observed, RDW test results are often used together with mean corpuscular volume (MCV) results to determine the possible causes of the anemia. It is mainly used to differentiate an anemia of mixed causes from an anemia of a single cause.",43.730000000000004
Mean spheric corpuscular volume,0.436831,3e-11,11q24.3,rs2250322,FLI1,Other trait,http://www.ebi.ac.uk/efo/EFO_0004526,A mean corpuscular volume is the result of calculation of the mean volume of erythrocytes in a blood sample.,43.6831
Hemoglobin,0.435744,6e-35,16q24.3,rs2250598,DPEP1,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004509,Hemoglobin measurement is a measure of the quantity of the metallo protein hemoglobin in blood often used in the diagnosis of anaemia.,43.574400000000004
Hematocrit,0.435711,2e-36,16q24.3,rs2250598,DPEP1,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004348,"The volume of packed RED BLOOD CELLS in a blood specimen. The volume is measured by centrifugation in a tube with graduated markings, or with automated blood cell counters. It is an indicator of erythrocyte status in disease. For example, ANEMIA shows a low value; POLYCYTHEMIA, a high value.",43.5711
Receptor tyrosine-protein kinase erbB-3 levels,0.434783,4e-10,12q13.2,rs10876870,ERBB3,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0004747,"Is a quantification of some protein, typically obtained from an individual with the intention of using the measurement in some diagnostic process.",43.4783
"high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed)",0.429,6e-32,6p21.31,rs4711396,ILRUN,Cardiovascular disease,http://www.ebi.ac.uk/efo/EFO_0004612,The measurement of HDL cholesterol in blood used as a risk indicator for heart disease.,42.9
"high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed)",0.429,9.999999999999999e-33,6p21.31,rs4711396,ILRUN,Cardiovascular disease,http://www.ebi.ac.uk/efo/EFO_0004612,The measurement of HDL cholesterol in blood used as a risk indicator for heart disease.,42.9
Metabolite levels (1-(1-enyl-palmitoyl)-GPC (P-16:0); C16:1 LPC plasmalogen),0.4267,5e-25,11q12.2,rs174567,"FADS2, FADS1",Other trait,http://www.ebi.ac.uk/efo/EFO_0005664,quantification of some metabolite in blood,42.67
Cholesteryl ester levels,0.4248,1e-07,11q12.2,rs174566,"FADS1, FADS2",Other trait,http://www.ebi.ac.uk/efo/EFO_0008589,Quantification of the amount of esterified cholesterol in a sample.,42.480000000000004
"white blood cell count (WBC, maximum, inv-norm transformed)",0.4214,5e-50,17q21.1,rs8070444,PSMD3,Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0004308,The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells.,42.14
Polycystic ovary syndrome,0.42,5e-09,12q13.2,rs2271194,ERBB3,Other disease,http://www.ebi.ac.uk/efo/EFO_0000660,"A disorder that manifests as multiple cysts on the ovaries. It results in hormonal imbalances and leads to irregular and abnormal menstrual periods, excess growth of hair, acne eruptions and obesity.",42.0
Pulse pressure x alcohol consumption interaction (2df test),0.42,6e-23,8p23.1,rs11993089,MSRA,Cardiovascular measurement,"http://www.ebi.ac.uk/efo/EFO_0005763, http://www.ebi.ac.uk/efo/EFO_0004329",,42.0
Crohn's disease (indolent vs progressive),0.419929,4e-06,7p22.2,rs4723416,SDK1,Digestive system disease,"http://www.ebi.ac.uk/efo/EFO_0008336, http://www.ebi.ac.uk/efo/EFO_0000384",,41.9929
Parkinson's disease (age of onset),0.4146,3e-06,20q13.13,rs1973946,SCREEM1 - TRERNA1,Nervous system disease,http://purl.obolibrary.org/obo/OBA_2001009,Ontology not covered,41.46
Cigarettes smoked per day,0.414,1e-18,1q21.3,rs2072659,CHRNB2,Immune system disease,http://www.ebi.ac.uk/efo/EFO_0006525,the quantification of the number of cigarettes that a subject smoked on average per day,41.4
Pleckstrin homology domain-containing family B member 1 levels,0.410317,2e-22,11q13.4,rs10793065,PLEKHB1,Other trait,http://www.ebi.ac.uk/efo/EFO_0004747,"Is a quantification of some protein, typically obtained from an individual with the intention of using the measurement in some diagnostic process.",41.0317
Phosphatidylethanolamine (18:0_18:2) levels,0.409153,1e-92,11q12.2,rs174567,"FADS2, FADS1",Other trait,http://purl.obolibrary.org/obo/OBA_2045139,Ontology not covered,40.9153
Phosphatidylcholine (O-18:2_16:0) levels,0.408433,4e-18,11q12.2,rs174566,"FADS1, FADS2",Other trait,http://purl.obolibrary.org/obo/OBA_2045132,Ontology not covered,40.8433
Phosphatidylcholine (15:0_18:2) levels,0.408433,1e-73,11q12.2,rs174566,"FADS1, FADS2",Other trait,http://purl.obolibrary.org/obo/OBA_2045065,Ontology not covered,40.8433
Phosphatidylcholine (17:0_18:2) levels,0.408433,9e-53,11q12.2,rs174566,"FADS1, FADS2",Other trait,http://purl.obolibrary.org/obo/OBA_2045086,Ontology not covered,40.8433
Phosphatidylinositol (18:0_18:2) levels,0.408433,4e-67,11q12.2,rs174566,"FADS1, FADS2",Other trait,http://purl.obolibrary.org/obo/OBA_2045156,Ontology not covered,40.8433
Eosinophil percentage of white cells,0.397535,9e-10,8p21.2,rs4733063,PTK2B,Other trait,http://www.ebi.ac.uk/efo/EFO_0007991,"A calculated measurement in which the number of eosinophil granulocytes is divided by the number of all white blood cells in a specified sample of peripheral venous blood, and the result presented as a ratio, fraction, quotient or percentage. An eosinophil is a granular leukocyte having a nucleus with two lobes connected by a thread of chromatin, and cytoplasm containing coarse, round granules of uniform size that stain readily with eosin and other acid dyes.",39.7535
Matrix metalloproteinase-9 levels,0.39,1e-13,17q21.1,rs3826331,PSMD3,Other trait,http://www.ebi.ac.uk/efo/EFO_0020561,The determination of the amount of matrix metalloproteinase-9 in a sample,39.0
Sex hormone-binding globulin levels in premenopausal women,0.38738,3e-09,6q25.1,rs1738386,ESR1,Other trait,http://www.ebi.ac.uk/efo/EFO_0004696,"Is a quantification of sex hormone binding globulin. In men the test is used in when investigating testosterone deficiency. The SHBG glycoprotein binds to circulating estradiol and testosterone, low levels of SHBG may be implicated in breast cancer etiology.",38.738
"COVID-19 (hospitalized vs tested, not hospitalized)",0.38723602,8e-06,6p22.3,rs493024,ID4 - RPL29P17,Other measurement,http://purl.obolibrary.org/obo/MONDO_0100096,A disease caused by infection with severe acute respiratory syndrome coronavirus 2.,38.723602
COVID-19 (hospitalized vs population),0.38503273,4e-06,6p22.3,rs493024,ID4 - RPL29P17,Other trait,http://purl.obolibrary.org/obo/MONDO_0100096,A disease caused by infection with severe acute respiratory syndrome coronavirus 2.,38.503273
Ulcerative colitis,0.38,6e-06,2q24.1,rs8179646,LINC01958 - RPLP0P7,Digestive system disease,http://www.ebi.ac.uk/efo/EFO_0000729,"An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.",38.0
Sex hormone-binding globulin levels adjusted for BMI,0.379996,2e-11,6q25.1,rs1738386,ESR1,Body measurement,http://www.ebi.ac.uk/efo/EFO_0004696,"Is a quantification of sex hormone binding globulin. In men the test is used in when investigating testosterone deficiency. The SHBG glycoprotein binds to circulating estradiol and testosterone, low levels of SHBG may be implicated in breast cancer etiology.",37.9996
Alzheimer's disease or educational attainment (pleiotropy),0.3787,2e-17,2q11.2,rs12987662,AFF3 - LINC01104,Nervous system disease,"http://purl.obolibrary.org/obo/MONDO_0004975, http://www.ebi.ac.uk/efo/EFO_0011015",,37.87
BMI at birth,0.376996,5e-17,17p13.1,rs739669,"DLG4, ACADVL",Body measurement,http://www.ebi.ac.uk/efo/EFO_0004340,"An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight (kg)/height squared (m2). BMI correlates with body fat (ADIPOSE TISSUE). Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 (underweight); 18.5-24.9 (normal); 25.0-29.9 (overweight); 30.0 and above (obese). (National Center for Health Statistics, Centers for Disease Control and Prevention)",37.6996
Longevity,0.37,1e-07,14q23.3,rs1950902,MTHFD1,Other trait,http://www.ebi.ac.uk/efo/EFO_0004300,The length of time of an organism's life.,37.0
"diastolic blood pressure (DBP, maximum, inv-normal transformed)",0.37,3e-12,2p22.1,rs2041764,SLC8A1,Cardiovascular disease,http://www.ebi.ac.uk/efo/EFO_0006336,The blood pressure after the contraction of the heart while the chambers of the heart refill with blood.,37.0
Metabolic biomarkers (multivariate analysis),0.37,9e-24,19p13.11,rs11666808,IQCN,Metabolic disease,"http://www.ebi.ac.uk/efo/EFO_0004736, http://www.ebi.ac.uk/efo/EFO_0004735, http://www.ebi.ac.uk/efo/EFO_0009946, http://www.ebi.ac.uk/efo/EFO_0007800, http://www.ebi.ac.uk/efo/EFO_0004612, http://www.ebi.ac.uk/efo/EFO_0004696",,37.0
Self-reported math ability,0.3699,1e-08,16q23.3,rs4075464,CDH13,Other trait,http://www.ebi.ac.uk/efo/EFO_0004875,"Is the mental process necessary to acquire knowledge or skill in the measurement, properties, and relationships of quantities and sets, using numbers and symbols (mathematics)",36.99
Cognitive aspects of educational attainment,0.368787,7e-09,17q22,rs2302189,MTMR4,Nervous system disease,"http://www.ebi.ac.uk/efo/EFO_0008354, http://www.ebi.ac.uk/efo/EFO_0004784",,36.878699999999995
"monocyte (absolute count, minimum, inv-norm transformed)",0.3657,1e-38,19p13.11,rs1075403,IQCN,Other trait,http://www.ebi.ac.uk/efo/EFO_0005091,quantification of monocytes in the blood,36.57
Type 2 diabetes,0.36546,1e-11,20q13.2,rs507381,LINC01440,Metabolic disease,http://purl.obolibrary.org/obo/MONDO_0005148,A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.,36.546
"monocyte (fraction, minimum, inv-norm transformed)",0.3654,1e-45,19p13.11,rs1075403,IQCN,Other trait,http://www.ebi.ac.uk/efo/EFO_0005091,quantification of monocytes in the blood,36.54
Cortical thickness,0.3648,1e-17,10p11.23,rs11008282,ZNF438,Other trait,http://www.ebi.ac.uk/efo/EFO_0004840,"Is a quantification of the thickness of brain cortex, e.g. measured by MRI, used in the diagnosis of Alzheimer's disease and other neurological conditions",36.480000000000004
Cortical surface area,0.3647,1e-17,10p11.23,rs11008281,ZNF438,Other trait,http://www.ebi.ac.uk/efo/EFO_0010736,Quantification of the surface area of the cerebral cortex or parts thereof.,36.47
Posterior thigh muscle fat infiltration percentage,0.36,2e-13,19p13.11,rs10416600,IQCN - JUND,Other trait,http://www.ebi.ac.uk/efo/EFO_0020934,Quantification of some aspect of the posterior thigh muscle fat infiltration.,36.0
Cholesteryl ester (20:4) levels,0.358418375,8e-22,11q12.2,rs174567,"FADS2, FADS1",Other trait,http://www.ebi.ac.uk/efo/EFO_0010348,The quantification of cholesteryl ester 20:4 levels in a sample.,35.841837500000004
Triglyceride to HDL cholesterol ratio,0.351,3e-129,11q12.2,rs174566,"FADS1, FADS2",Cardiovascular disease,http://www.ebi.ac.uk/efo/EFO_0007929,quantification of the ratio of triglyceride to HDL cholesterol in a sample,35.099999999999994
Aspartate aminotransferase platelet ratio index in high alcohol intake,0.3502,2e-08,11q12.2,rs174566,"FADS1, FADS2",Hematological measurement,http://www.ebi.ac.uk/efo/EFO_0010576,"Quantification of the invasion of fibrous connective tissue into the liver, typically by histological assessment of biopsy samples.",35.02
Asthma in any disease,0.35,1e-08,11q12.2,rs174566,"FADS1, FADS2",Immune system disease,http://purl.obolibrary.org/obo/MONDO_0004979,"A bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors resulting in recurring periods of wheezing (a whistling sound while breathing), chest tightness, shortness of breath, mucus production and coughing. The symptoms appear due to a variety of triggers such as allergens, irritants, respiratory infections, weather changes, exercise, stress, reflux disease, medications, foods and emotional anxiety.",35.0
Phospholipids in large HDL (UKB data field 23560),0.347136,2e-68,11q12.2,rs174566,"FADS1, FADS2",Lipid or lipoprotein measurement,http://www.ebi.ac.uk/efo/EFO_0022190,Quantification of phospholipids in large HDL.,34.7136
IgG glycosylation,0.346381764494382,2e-08,6p21.32,rs1049110,HLA-DQB2,Immune system disease,http://www.ebi.ac.uk/efo/EFO_0005193,quantification of N-linked IgG glycans in a serum sample,34.6381764494382
1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) levels,0.344891,4e-14,11q12.2,rs174566,"FADS1, FADS2",Other trait,http://www.ebi.ac.uk/efo/EFO_0800470,Quantification of the amount of 1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) in a sample.,34.4891
Vertex-wise cortical thickness,0.34,1e-20,10p11.23,rs11008282,ZNF438,Other trait,http://www.ebi.ac.uk/efo/EFO_0004840,"Is a quantification of the thickness of brain cortex, e.g. measured by MRI, used in the diagnosis of Alzheimer's disease and other neurological conditions",34.0
Vertex-wise sulcal depth,0.34,2.9999999999999987e-47,10p11.23,rs2000099,ZNF438,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0004464,Description not found,34.0
QT interval,0.33,2e-39,10p12.2,rs7098978,RNU6-413P - ARMC3,Cardiovascular measurement,http://www.ebi.ac.uk/efo/EFO_0004682,The QT interval is a measure of the time between the start of the Q wave and the end of the T wave in the heart's electrical cycle,33.0
Waist-to-hip ratio adjusted for body mass index,0.3269,6e-09,5q13.3,rs167025,LINC01331,Body measurement,"http://www.ebi.ac.uk/efo/EFO_0007788, http://www.ebi.ac.uk/efo/EFO_0008002",,32.690000000000005
Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction),0.3269,4e-09,5q13.3,rs167025,LINC01331,Body measurement,"http://www.ebi.ac.uk/efo/EFO_0007788, http://www.ebi.ac.uk/efo/EFO_0008002",,32.690000000000005
Waist-to-hip ratio adjusted for BMI in active individuals,0.3259,3e-06,5q13.3,rs167025,LINC01331,Nervous system disease,http://www.ebi.ac.uk/efo/EFO_0007788,waist-hip ratio that has been adjusted by subjects’ body mass index,32.59
Metabolite levels (stearoyl-arachidonoyl-glycerophosphoinositol (1)),0.3256,2e-11,11q12.2,rs174566,"FADS1, FADS2",Other trait,http://www.ebi.ac.uk/efo/EFO_0803575,Quantification of stearoyl-arachidonoyl-glycerophosphoinositol (1) in a sample.,32.56
Psoriasis vulgaris,0.3201,5e-17,6q23.3,rs610604,TNFAIP3,Immune system disease,http://www.ebi.ac.uk/efo/EFO_1001494,"Plaque psoriasis is the most common presentation of psoriasis. It presents as small to large, well demarcated, red, scaly and thickened areas of skin. It most likely to affect elbows, knees, and lower back but may arise on any part of the body.",32.01
Cutaneous psoriasis,0.3201,8e-11,6q23.3,rs610604,TNFAIP3,Immune system disease,"http://www.ebi.ac.uk/efo/EFO_0007773, http://www.ebi.ac.uk/efo/EFO_0000676",,32.01
"Plasma 1,2-dilinoleoyl-GPC (18:2/18:2) levels in chronic kidney disease",0.32,2e-31,11q12.2,rs174567,"FADS2, FADS1",Other disease,http://www.ebi.ac.uk/efo/EFO_0800388,"Quantification of the amount of 1,2-dilinoleoyl-GPC (18:2/18:2) in a sample.",32.0
Plasma 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) levels in chronic kidney disease,0.32,2e-18,11q12.2,rs174567,"FADS2, FADS1",Other disease,http://www.ebi.ac.uk/efo/EFO_0800413,Quantification of the amount of 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) in a sample.,32.0
Plasma stearidonate (18:4n3) levels in chronic kidney disease,0.32,2e-12,11q12.2,rs174567,"FADS2, FADS1",Other disease,http://www.ebi.ac.uk/efo/EFO_0021075,Quantification of the amount of stearidonate 18:4n3 in a sample.,32.0
Delta-5 desaturase activity response to n3-polyunsaturated fat supplement,0.32,1e-12,11q12.2,rs174566,"FADS1, FADS2",Response to drug,"http://www.ebi.ac.uk/efo/EFO_0007764, http://www.ebi.ac.uk/efo/EFO_0009131",,32.0
Plasma 1-linoleoyl-GPE (18:2)* levels in chronic kidney disease,0.32,3e-21,11q12.2,rs174567,"FADS2, FADS1",Other disease,http://www.ebi.ac.uk/efo/EFO_0800247,Quantification of the amount of 1-linoleoyl-GPE (18:2) in a sample.,32.0
Psoriatic arthritis,0.32,8e-09,6q23.3,rs610604,TNFAIP3,Other trait,http://www.ebi.ac.uk/efo/EFO_0003778,"A type of inflammatory arthritis associated with PSORIASIS, often involving the axial joints and the peripheral terminal interphalangeal joints. It is characterized by the presence of HLA-B27-associated SPONDYLARTHROPATHY, and the absence of rheumatoid factor.",32.0
Plasma 1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) levels in chronic kidney disease,0.32,5.9999999999999996e-40,11q12.2,rs174567,"FADS2, FADS1",Other disease,http://www.ebi.ac.uk/efo/EFO_0800610,Quantification of the amount of 1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) in a sample.,32.0
Plasma 1-stearoyl-2-linoleoyl-GPC (18:0/18:2)* levels in chronic kidney disease,0.32,5e-23,11q12.2,rs174567,"FADS2, FADS1",Other disease,http://www.ebi.ac.uk/efo/EFO_0800404,Quantification of the amount of 1-stearoyl-2-linoleoyl-GPC (18:0/18:2) in a sample.,32.0
Postprandial estimated degree of unsaturation,0.31970264,5e-52,11q12.2,rs174566,"FADS1, FADS2",Other trait,http://www.ebi.ac.uk/efo/EFO_0005110,The determination of the amount of fatty acids present in a sample.,31.970263999999997
Gamma glutamyl transpeptidase,0.308142,4e-08,17q12,rs12951345,HNF1B,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0004532,Serum gamma-glutamyl transferase level measurement is the quantification of gamma-glutamyl transferase in blood. Gamma-glutamyl transferase is used as a marker for liver/bile duct problems and alcohol abuse.,30.814200000000003
Serum levels of protein WFDC1,0.2996,4e-19,1p13.3,rs10127790,SORT1,Other trait,http://www.ebi.ac.uk/efo/EFO_0007937,quantification of the levels of some protein in a blood sample,29.959999999999997
Risk-taking tendency (4-domain principal component model),0.2975,7e-10,3p14.2,rs10866054,CADPS,Other trait,http://www.ebi.ac.uk/efo/EFO_0008579,"The tendency to take risks. Risk-taking behaviour is a characteristic of several psychiatric disorders such as ADHD and bipolar disorder, as well as problem behaviours such as smoking and drug abuse.",29.75
QRS duration,0.295492,4e-24,12q24.21,rs7966651,TBX3-AS1 - UBA52P7,Other trait,http://www.ebi.ac.uk/efo/EFO_0005055,"QRS duration is a measurement of the combined duration of the Q, R and S waves of the human heart's electric cycle",29.5492
Cerebrospinal AB1-42 levels in Alzheimer's disease dementia,0.29,3e-07,19q13.32,rs283812,NECTIN2,Nervous system disease,http://www.ebi.ac.uk/efo/EFO_0004670,Is the quantification of Beta-amyloid 1-42 in cerebrospinal fluid typically used as a biomarker for Alzheimer's Disease,28.999999999999996
Ectonucleoside triphosphate diphosphohydrolase 5 levels,0.287053,1.9999999999999998e-32,14q24.3,rs1968105,PTGR2,Other trait,http://www.ebi.ac.uk/efo/EFO_0008115,quantification of the amount of ectonucleoside triphosphate diphosphohydrolase 5 in a sample,28.7053
Serum levels of protein CLEC11A,0.2857,1e-16,19q13.33,rs62112533,CLEC11A - GPR32P1,Other trait,http://www.ebi.ac.uk/efo/EFO_0007937,quantification of the levels of some protein in a blood sample,28.57
Calculus of kidney (PheCode 594.1),0.2791,9e-17,3q21.1,rs6767061,CASR,Other trait,http://www.ebi.ac.uk/efo/EFO_0004253,Formation of stones in the KIDNEY.,27.91
Glutathione S-transferase Mu 5 levels,0.270917,1e-57,1p13.3,rs929166,GSTM5,Other trait,http://www.ebi.ac.uk/efo/EFO_0004747,"Is a quantification of some protein, typically obtained from an individual with the intention of using the measurement in some diagnostic process.",27.091700000000003
Kidney stones,0.268,2e-08,3q21.1,rs7627468,CASR,Other trait,http://www.ebi.ac.uk/efo/EFO_0004253,Formation of stones in the KIDNEY.,26.8
Suffering from nerves,0.263176,5e-10,18q21.32,rs11665052,RNU4-17P - MC4R,Other trait,http://purl.obolibrary.org/obo/NCIT_C74532,Ontology not covered,26.317600000000002
ICOS ligand levels,0.26,7e-12,8p23.1,rs56136595,DEFA4 - DEFA8P,Immune system disease,http://www.ebi.ac.uk/efo/EFO_0020460,The determination of the amount of icos ligand in a sample,26.0
Puberty onset,0.26,5e-06,1p36.23,rs1149332,CAMTA1,Other trait,http://www.ebi.ac.uk/efo/EFO_0005677,quantification of the onset of puberty in human males and females through a series of proxy measurements such as genital enlargement (males) or breast development (females). These characteristics are assessed based on pre-defined scales either through self-reporting or through assessment by a medical professional.,26.0
Gout (PheCode 274.1),0.2578,2e-12,10q26.13,rs4962696,EEF1AKMT2,Other trait,http://www.ebi.ac.uk/efo/EFO_0004274,"A condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals.",25.779999999999998
Creatinine levels (UKB data field 23478),0.254194,3e-13,17q12,rs113414512,FBXL20,Other trait,http://www.ebi.ac.uk/efo/EFO_0004518,"A creatinine measurement is a measure of the metabolite creatinine in a sample. For example, in the serum, where it can be used in assessment of kidney function.",25.419399999999996
Myeloblastin (analyte X13720.95) levels,0.249272,8e-11,19p13.3,rs3786991,AZU1 - PRTN3,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0004747,"Is a quantification of some protein, typically obtained from an individual with the intention of using the measurement in some diagnostic process.",24.9272
Myeloblastin (analyte X3514.49) levels,0.241966,6e-21,19p13.3,rs2074638,AZU1 - PRTN3,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0004747,"Is a quantification of some protein, typically obtained from an individual with the intention of using the measurement in some diagnostic process.",24.1966
Obesity,0.24,2e-36,18q21.32,rs538656,RNU4-17P - MC4R,Metabolic disease,http://www.ebi.ac.uk/efo/EFO_0001073,A disorder involving an excessive amount of body fat.,24.0
Multiple system atrophy,0.24,7e-06,19q12,rs11084877,LINC02987 - MAN1A2P1,Other trait,http://www.ebi.ac.uk/efo/EFO_1001050,"A progressive neurodegenerative condition of the central and autonomic nervous systems characterized by atrophy of the preganglionic lateral horn neurons of the thoracic spinal cord. This disease is generally considered a clinical variant of MULTIPLE SYSTEM ATROPHY. Affected individuals present in the fifth or sixth decade with ORTHOSTASIS and bladder dysfunction; and later develop FECAL INCONTINENCE; anhidrosis; ATAXIA; IMPOTENCE; and alterations of tone suggestive of basal ganglia dysfunction. (From Adams et al., Principles of Neurology, 6th ed, p536)",24.0
Systemic lupus erythematosus,0.237,5e-43,6p21.32,rs7753017,HLA-DQB2,Immune system disease,http://purl.obolibrary.org/obo/MONDO_0007915,An autoimmune multi-organ disease typically associated with vasculopathy and autoantibody production. Most patients have antinuclear antibodies (ANA). The presence of anti-dsDNA or anti-Smith antibodies are highly-specific.,23.7
Feeling worry,0.236497,7e-10,18q21.32,rs58084604,RNU4-17P - MC4R,Other trait,http://www.ebi.ac.uk/efo/EFO_0009589,Quantification of whether an individual feels or felt worried.,23.649700000000003
Body mass index in physically inactive individuals,0.2354,2e-11,18q21.32,rs17782313,RNU4-17P - MC4R,Nervous system disease,http://www.ebi.ac.uk/efo/EFO_0004340,"An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight (kg)/height squared (m2). BMI correlates with body fat (ADIPOSE TISSUE). Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 (underweight); 18.5-24.9 (normal); 25.0-29.9 (overweight); 30.0 and above (obese). (National Center for Health Statistics, Centers for Disease Control and Prevention)",23.54
Age of smoking initiation,0.235,1e-19,18q21.32,rs538656,RNU4-17P - MC4R,Other trait,http://www.ebi.ac.uk/efo/EFO_0021784,"Age of initation of the habit of smoking, the inhaling and exhaling of tobacco smoke.",23.5
Predicted visceral adipose tissue,0.2347,1.9999999999999998e-54,18q21.32,rs538656,RNU4-17P - MC4R,Other trait,http://www.ebi.ac.uk/efo/EFO_0004765,Is a quantification of a particular location of adipose tissue.,23.47
Gout,0.2331,1e-27,18q21.32,rs538656,RNU4-17P - MC4R,Other trait,http://www.ebi.ac.uk/efo/EFO_0004274,"A condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals.",23.31
Detectable estradiol levels in premenopausal women,0.227088,7e-07,8p11.23,rs28807105,EIF4EBP1,Other trait,http://www.ebi.ac.uk/efo/EFO_0004697,Is a quantification of circulating estradiol a circulating steriod sex hormone.,22.7088
Detectable estradiol levels in postmenopausal women,0.227088,9e-09,8p11.23,rs28807105,EIF4EBP1,Other trait,http://www.ebi.ac.uk/efo/EFO_0004697,Is a quantification of circulating estradiol a circulating steriod sex hormone.,22.7088
Neurociticism,0.224224,6e-09,9p23,rs11496294,AKAP8P1 - JKAMPP1,Nervous system disease,http://www.ebi.ac.uk/efo/EFO_0007660,"Quantification of some aspect of neuroticism or neurotic behaviour, such as severity or frequency of neurotic behaviour. This is usually assessed via a standardised questionnaire.",22.4224
"What is your weight? (pounds, inv-normal transformed)",0.2229,9.000000000000001e-23,3q21.3,rs4073154,H1-10-AS1,Body measurement,http://www.ebi.ac.uk/efo/EFO_0004338,The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.,22.29
Sudden cardiac arrest,0.22,4e-08,5q22.2,rs4621553,YTHDC2 - KCNN2,Other trait,http://www.ebi.ac.uk/efo/EFO_0004278,"Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)",22.0
Feeling nervous,0.216145,1e-10,6p21.32,rs377763,NOTCH4 - TSBP1-AS1,Nervous system disease,http://www.ebi.ac.uk/efo/EFO_0009597,"Quantification of whether an individual feels or felt nervous or ""suffered from nerves"".",21.6145
Positive affect,0.2144,2e-06,11p11.2,rs10769190,PHF21A - FBLIM1P2,Other trait,http://www.ebi.ac.uk/efo/EFO_0007869,"quantification of some aspect of wellbeing such as life satisfaction or emotional wellbeing, usually self-reported and quantified through the use of a structured questionnaire",21.44
Obesity-related traits,0.213,3e-07,7p15.3,rs10950840,LINC01162 - RN7SL542P,Metabolic disease,http://www.ebi.ac.uk/efo/EFO_0005116,quantification of some metabolite in urine,21.3
"What is your height? (cm, inv-normal transformed)",0.208,3e-26,3q21.3,rs4073154,H1-10-AS1,Body measurement,http://www.ebi.ac.uk/efo/EFO_0004339,The distance from the sole to the crown of the head with body standing on a flat surface and fully extended.,20.8
Immature fraction of reticulocytes,0.203393,3e-15,20q11.22,rs2425044,EIF6,Other trait,http://www.ebi.ac.uk/efo/EFO_0010700,"A quantification of some aspect of reticulocyte function, quantity, or composition.",20.339299999999998
High light scatter reticulocyte count,0.203381,2e-13,20q11.22,rs2425044,EIF6,Other trait,http://www.ebi.ac.uk/efo/EFO_0007986,The number of reticulocytes per unit volume of blood. Reticulocytes are immature red blood cells and typically compose aoubt 1% of red blood cells in the human body.,20.3381
High light scatter reticulocyte percentage of red cells,0.203377,2e-21,20q11.22,rs2425044,EIF6,Other trait,http://www.ebi.ac.uk/efo/EFO_0010700,"A quantification of some aspect of reticulocyte function, quantity, or composition.",20.3377
Sick sinus syndrome,0.201,8e-10,16q22.3,rs12932445,ZFHX3,Other disease,http://purl.obolibrary.org/obo/MONDO_0012061,"Sick sinus syndrome is a rare cardiac rhythm disease, usually of the elderly, characterized by electrocardiographic findings of sinus bradycardia, atrial fibrillation, atrial tachycardia sinus arrest, or sino-atrial block, and that manifest with symptoms like syncope, dizziness, palpitations, fatigue, or even heart failure. It results from malfunction of the cardiac conduction system, probably secondary to degenerative fibrosis of nodal tissue in the elderly or secondary to cardiac disorders in younger patients.",20.1
First fracture in long-term childhood cancer survivors (time to event),0.2,8e-09,16p13.3,rs1406815,HAGHL,Cancer,http://www.ebi.ac.uk/efo/EFO_0003931,Breaks in bones.,20.0
Smoking initiation (ever regular vs never regular),0.2,5e-14,2q36.3,rs4674993,NYAP2,Other trait,http://www.ebi.ac.uk/efo/EFO_0006527,"self-reported binary measure, used to denote whether an individual is currently or has ever been a smoker",20.0
Glutathione S-transferase Mu 1 (analyte X7239.9) levels,0.181347,9e-39,1p13.3,rs1292096,GSTM2 - GSTM5,Other trait,http://www.ebi.ac.uk/efo/EFO_0004747,"Is a quantification of some protein, typically obtained from an individual with the intention of using the measurement in some diagnostic process.",18.134700000000002
Keratinocyte cancer (MTAG),0.179072,6e-66,20p13,rs214803,TGM3,Cancer,http://www.ebi.ac.uk/efo/EFO_0010176,A skin cancer arising from the keratin-producing cells of the epidermis. The term encompasses both basal cell carcinoma and squamous cell carcinoma.,17.9072
Medication use (agents acting on the renin-angiotensin system),0.177701,7e-11,17p13.2,rs12453576,LINC01975,Response to drug,http://www.ebi.ac.uk/efo/EFO_0009931,Quantification of some aspect of the use of agents acting on the renin-angiotensin system.,17.7701
Oncostatin-M-specific receptor subunit beta levels,0.176215,2e-35,5p13.1,rs10941412,OSMR,Liver enzyme measurement,http://www.ebi.ac.uk/efo/EFO_0004747,"Is a quantification of some protein, typically obtained from an individual with the intention of using the measurement in some diagnostic process.",17.6215
Adiponectin levels,0.162,2e-06,14q32.11,rs12887387,RN7SKP255 - CHORDC2P,Other trait,http://www.ebi.ac.uk/efo/EFO_0004502,"Adiponectin measurement is a measurement of the circulating hormone adiponectin in serum. Adiponectin regulated modulates glucose regulation and fatty acid catabolism. Low circulating adiponectin concentrations (hypoadiponectinemia; <4 μg/mL) are associated with a variety of diseases, including dysmetabolism (type 2 diabetes, insulin resistance, hypertension, dyslipidemia, metabolic syndrome, hyperuricemia), atherosclerosis (coronary artery disease, stroke, peripheral artery disease), sleep apnea, non-alcoholic fatty liver disease, gastritis and gastro-esophageal reflux disease, inflammatory bowel diseases, pancreatitis, osteoporosis, and cancer (endometrial cancer, postmenopausal breast cancer, leukemia, colon cancer, gastric cancer, prostate cancer). Hyperadiponectinemia is associated with cardiac, renal and pulmonary diseases.",16.2
Vertex-wise cortical surface area,0.16,2e-09,6q23.2,rs12663047,ENPP3,Other trait,http://www.ebi.ac.uk/efo/EFO_0010736,Quantification of the surface area of the cerebral cortex or parts thereof.,16.0
Brain surface area change rate x age interaction (2df),0.1593,2e-08,19q13.32,rs34342646,NECTIN2,Nervous system disease,"http://www.ebi.ac.uk/efo/EFO_0021503, http://www.ebi.ac.uk/efo/EFO_0008007",,15.93
Facial emotion recognition (angry faces),0.156,3e-06,12p11.22,rs4930838,CCDC91 - FAR2,Other trait,http://www.ebi.ac.uk/efo/EFO_0008329,quantification of some aspect of facial emotion recognition such as ability to differentiate between different emotions,15.6
Cognitive performance,0.1398,9e-06,13q31.2,rs969962,TET1P1 - LINC00373,Nervous system disease,http://www.ebi.ac.uk/efo/EFO_0003926,Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury.,13.98
Cerebral amyloid deposition (PET imaging),0.13,2e-12,19q13.32,rs34342646,NECTIN2,Other trait,http://www.ebi.ac.uk/efo/EFO_0007707,quantification by PET scan imaging or other techniques of the deposition of amyloid proteins in any part of the cerebral cortex,13.0
Restless legs syndrome,0.128886015953928,1e-12,15q25.1,rs1319940,TFDP1P3 - RPL7L1P15,Other disease,http://www.ebi.ac.uk/efo/EFO_0004270,A condition that occurs while resting or lying in bed; it is characterized by an irresistible urgency to move the legs to obtain relief from a strange and uncomfortable sensation in the legs.,12.888601595392801
Mean arterial pressure,0.1258,2e-10,17q21.32,rs890431,HOXB7,Cardiovascular measurement,http://www.ebi.ac.uk/efo/EFO_0006340,"The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure.",12.58
Vaginal discharge (itching),0.125211826,4e-06,1q21.3,rs4292956,CHRNB2,Other trait,http://www.ebi.ac.uk/efo/EFO_0009409,Itching in the vagina from abnormal discharge.,12.5211826
Basophil side fluorescence,0.1213,1e-10,1p22.3,rs1888341,LINC02801,Other trait,http://www.ebi.ac.uk/efo/EFO_0803539,"Quantification of some aspect of basophils, such as function, quantity or composition.",12.13
Basophil forward scatter distribution width,0.1207,4e-17,1p22.3,rs1888342,LINC02801,Other trait,http://www.ebi.ac.uk/efo/EFO_0803539,"Quantification of some aspect of basophils, such as function, quantity or composition.",12.07
Basophil side fluorescence distribution width,0.1197,1e-18,1p22.3,rs1888342,LINC02801,Other trait,http://www.ebi.ac.uk/efo/EFO_0803539,"Quantification of some aspect of basophils, such as function, quantity or composition.",11.97
Serum levels of protein CCL18,0.1162,4.000000000000001e-237,17q12,rs854469,CCL23 - CCL18,Other trait,http://www.ebi.ac.uk/efo/EFO_0007937,quantification of the levels of some protein in a blood sample,11.62
Serum levels of protein CCL3,0.1162,1.9999999999999998e-122,17q12,rs854469,CCL23 - CCL18,Other trait,http://www.ebi.ac.uk/efo/EFO_0010770,Quantification of the amount of CCL3 protein in a sample,11.62
Serum levels of protein CCL3L3,0.1162,3e-59,17q12,rs854469,CCL23 - CCL18,Other trait,http://www.ebi.ac.uk/efo/EFO_0007937,quantification of the levels of some protein in a blood sample,11.62
Chronic spontaneous urticaria,0.11,2e-15,19q13.42,rs434124,MIR4752 - LILRA5,Other disease,http://www.ebi.ac.uk/efo/EFO_0005531,"A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.",11.0
Hypertension,0.1026,1e-06,17q21.32,rs7406910,HOXB7,Cardiovascular disease,http://www.ebi.ac.uk/efo/EFO_0000537,"Persistently high systemic arterial blood pressure. Based on multiple readings (blood pressure determination), hypertension is currently defined as when systolic pressure is consistently greater than 140 mm Hg or when diastolic pressure is consistently 90 mm Hg or more.",10.26
Smoking behaviour (cigarettes smoked per day),0.102,3e-13,1q21.3,rs2072659,CHRNB2,Immune system disease,http://www.ebi.ac.uk/efo/EFO_0006525,the quantification of the number of cigarettes that a subject smoked on average per day,10.2
CD20 on CD24+ CD27+ B cell,0.09172,1e-11,11q12.2,rs139706128,MS4A14,Other trait,http://www.ebi.ac.uk/efo/EFO_0007937,quantification of the levels of some protein in a blood sample,9.171999999999999
Low hand grip strength,0.08854,2e-06,11q11,rs118154365,OR4A9P - OR4X7P,Other trait,http://www.ebi.ac.uk/efo/EFO_0006941,quantification of the force applied by the hand to pull on or suspend from objects,8.854
Fever in mesalamine-treated irritable bowel disease,0.0823,1e-07,22q13.1,rs397822879,TPTEP2-CSNK1E - KCNJ4,Digestive system disease,"http://purl.obolibrary.org/obo/OBA_2040137, http://purl.obolibrary.org/obo/HP_0001945",,8.23
Systolic blood pressure night-to-day ratio in hypertension,0.08,1e-08,14q32.2,rs4905794,RPL3P4 - BCL11B,Cardiovascular disease,http://www.ebi.ac.uk/efo/EFO_0006944,quantification of any change in an indiviual's systolic blood pressure,8.0
Glomerular filtration rate change in heart transplantation,0.08,2e-06,5q31.3,rs918378,HMHB1 - RN7SL87P,Cardiovascular disease,"http://www.ebi.ac.uk/efo/EFO_0007043, http://www.ebi.ac.uk/efo/EFO_0006829",,8.0
Diastolic blood pressure night-to-day ratio in hypertension,0.08,2e-06,14q32.2,rs4905794,RPL3P4 - BCL11B,Cardiovascular disease,http://www.ebi.ac.uk/efo/EFO_0006945,quantification of any change in an indiviual's diastolic blood pressure,8.0
Eosinophilic esophagitis,0.0015,2e-08,18q12.2,rs534845465,INO80C - GALNT1,Other trait,http://www.ebi.ac.uk/efo/EFO_0004232,"Chronic ESOPHAGITIS characterized by esophageal mucosal EOSINOPHILIA. It is diagnosed when an increase in EOSINOPHILS are present over the entire esophagus. The reflux symptoms fail to respond to PROTON PUMP INHIBITORS treatment, unlike in GASTROESOPHAGEAL REFLUX DISEASE. The symptoms are associated with IgE-mediated hypersensitivity to food or inhalant allergens.",0.15
Diisocyanate-induced asthma,0.001,1e-06,12q13.13,rs59448276,"KRT86, KRT81",Immune system disease,"http://purl.obolibrary.org/obo/MONDO_0004979, http://www.ebi.ac.uk/efo/EFO_0006995",,0.1
>>>>>>> Stashed changes
